Modelling the natural history of primary progressive multiple sclerosis

Area of Science:

• Neurology
• Clinical Trials
• Epidemiology

Background:

• Primary progressive multiple sclerosis (PPMS) affects a minority of multiple sclerosis (MS) patients, with limited treatment options.
• Understanding contemporary outcome data is vital for designing effective interventional studies for PPMS.

Purpose of the Study:

• To compare disability progression in PPMS patients with relapsing-onset MS (ROMS) patients.
• To identify factors influencing disability accumulation in PPMS.
• To develop predictive models for clinical trial design in PPMS.

Main Methods:

• A population-based cohort of 2131 MS patients was analyzed, identifying 234 with PPMS.
• Survival analysis and Cox regression were used to compare time to disability endpoints and explore progression factors.
• Data were utilized to create predictive power models for PPMS clinical trials.

Main Results:

• PPMS patients reached disability milestones (EDSS 4.0, 6.0, 8.0) significantly faster than ROMS patients.
• Age at onset and cerebellar symptoms influenced the rate of disability progression.
• Clinical trial models suggest ~600 patients (EDSS 4.0) or ~400 patients (EDSS 5.0) are needed per arm to detect a 20% difference using EDSS change of 1.0.

Conclusions:

• Disability progression in PPMS is variable, influenced by age at onset, but age-related milestones are similar to ROMS.
• Clinical trial designs for PPMS should consider patient selection (initial EDSS < 6.0) and outcome measures.
• The study provides a contemporary framework for clinical trial design in progressive MS.